ALSO IN THIS MONTH'S ISSUE

• What’s True Of Mice ≠ What’s True Of Men

  As ATMPs advance, scientists are calling out the limited value of mouse models in pharmacological re-search and testing. LIfT Biosciences’ Founder and CEO Alex Blyth is a vocal proponent of organ-oid/tumoroid models.

• Data: The Future Of Regulatory Info Management In Europe

  The answer to many of our COVID-related real-world challenges lies in greater data centricity supported by the adoption of new technologies, and life sciences companies must play their own part in driving change.

• Where Bioprocessing Outsourcers Stand On Capacity Concerns

  Insights into bioprocessing outsourcers’ level of concern regarding current and upcoming avail-able capacity, whether they are currently facing limits, and what they plan to do about a potential shortage.

• How To Navigate Drug Repurposing And Bridging Studies

  Successful drug repurposing requires vision and intentionality. Drug sponsors should be aware that repurposed drug development requires the same careful planning as it does for a branded new drug.